assessment report - european medicines agency · ppk population pharmacokine tics . pr partial...

Download Assessment report - European Medicines Agency · PPK population pharmacokine tics . PR Partial response . PS performance status . Assessment report EMA/CHMP/271863/2017 Page 5/89

If you can't read please download the document

Upload: others

Post on 18-Feb-2020

2 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

CHMP assessment report · Bretaris Genuair CHMP assessment report EMA/CHMP/303918/2012 Page 6/76. Licensing status . A new application was filed in the US (23 June 2011) and Switzerland

CHMP assessment report...Jakavi CHMP assessment report Page 7/84 Scientific Advice The applicant received Scientific Advice from the CHMP on 20 November 2008, 18 December 2008, 05

Izba - CHMP Assessment report - EMEA/H/C/002738/0000

CHMP assessment report - European Medicines Agency · CHMP assessment report Envarsus EMA/CHMP/81205/2014 Page 5/118 . List of abbreviations . ADME Absorption and bioavailability,

CHMP ASSESSMENT REPORT Pradaxa › en › documents › assessment-report › pr… · Procedure No. EMEA/H/C/829 Assessment Report as adopted by the CHMP with all information of

CHMP assessment report · 25 July 2013 . EMA/CHMP/456924/2013 . Committee for Medicinal Products for Human Use (CHMP) CHMP assessment report . Xoterna Breezhaler . International non-proprietary

CHMP ASSESSMENT REPORT FOR INTELENCE · CHMP ASSESSMENT REPORT FOR INTELENCE International Nonproprietary Name: etravirine Procedure No. EMEA/H/C/000900 ... the criteria for accelerated

CHMP assessment report - European Medicines Agency...CHMP assessment report EMA/CHMP/207158/2013 Page 7/136 No 847/2000, the applicant did not submit a critical report addressing the

CHMP assessment report - European Medicines · PDF fileCommittee for Medicinal Products for Human Use (CHMP) CHMP assessment report . ... IKr Delayed rectifier potassium current

CHMP assessment report · CHMP assessment report EMA/CHMP/272283/2016 Page 9/86 1. Background information on the procedure 1.1. Submission of the dossier The applicant Samsung Bioepis

CHMP assessment report - European Medicines Agency · IB Investigator’s Brochure ICH International Conference on Harmonisation . CHMP assessment report ... USA or US United States

CHMP assessment report€¦ · CHMP assessment report EMA/CHMP/208477/2013 Page 9/136 September 2012. The Co-Rapporteur's first Assessment Report was circulated to all CHMP members

CHMP assessment report for paediatric use studies ......21 November 2013 EMA/CHMP/780068/2013 Committee for Medicinal Products for Human Use (CHMP) Synagis (Palivizumab) Procedure

Septembe˜SIMULCAST CALENDAR - Amazon S3 · Flamboro @ PPK Northfield @ PPK Rideau @ PPK Flagler Eve Mountaineer @TAM Red Mile @PPK Running Aces@PPK Pocono Downs@PPK Saratoga (H)@PPK

CHMP ASSESSMENT REPORT FOR Mozobil - Europa

CHMP ASSESSMENT REPORT FOR Vedrop · Assessment Report as adopted by the CHMP with all information of a commercially confidential nature deleted . ... • The Applicant submitted

PUBLIC CHMP ASSESSMENT REPORT FOR MEDICINAL …

Assessment report...London, 21 March 2013 EMA/CHMP/126714/2013 Committee for Medicinal Products for Human Use (CHMP) CHMP extension of indication variation assessment report Soliris

CHMP extension of indication variation assessment report

CHMP ASSESSMENT REPORT FOR Silodyx

CHMP assessment report - European Medicines Agency€¦ · 22 May 2014 . EMA/CHMP/231450/2014 . Committee for Medicinal Products for Human Use (CHMP) CHMP assessment report . Gazyvaro

CHMP ASSESSMENT REPORT Myfenax - ema.europa.eu

CHMP assessment report · CHMP assessment report EMA/CHMP/450053/2010 Page 3/57 1. Background information on the procedure 1.1. Submission of the dossier The applicant Pharming Group

CHMP assessment report - European Medicines Agency › en › documents › assessment-report › ... · CHMP assessment report . Mekinist . International non-proprietary name: trametinib

CHMP ASSESSMENT REPORT FOR Nymusa€¦ · CHMP ASSESSMENT REPORT FOR Nymusa International Nonproprietary Name: caffeine Procedure No. EMEA/H/C/001014 Assessment Report as adopted

Assessment report for paediatric studies submitted ... · Assessment report as adopted by the CHMP with all information of a commercially confidential ... PPK Per-protocol pharmacokinetic

CHMP ASSESSMENT REPORT FOR Doribax - Europa

CHMP ASSESSMENT REPORT FOR Ellaone · CHMP ASSESSMENT REPORT FOR Ellaone International Nonproprietary Name: ulipristal acetate ... as amended - complete and independent application

Assessment report - European Medicines Agency · 25 February 2016 . EMA/CHMP/190631/2016 . Committee for Medicinal Products for Human Use (CHMP) Assessment report . Taltz . Internationalnon

CHMP ASSESSMENT REPORT FOR Afinitor · Assessment Report as adopted by the CHMP with all information of a commercially confidential ... or study (ies). Information ... fermentation,

CHMP assessment report - European Medicines Agency › en › documents › assessment... · • The Rapporteur's first Assessment Report was circulated to all CHMP members on 14

CHMP assessment report - European Medicines Agency€¦ · CHMP assessment report EMA/CHMP/272283/2016 Page 3/86 intolerant to or have medical contraindications for such therapies

ella one chmp assessment report

CHMP assessment report - European Medicines Agency...Ryzodeg CHMP assessment report Page 6/151 development with specific focus on the carcinogenicity assessment. The agencies confirmed

CHMP extension of indication variation assessment …...London, 25 April 2014 EMA/CHMP/220738/2014 Committee for Medicinal Products for Human Use (CHMP) CHMP extension of indication